Sonoma Pharmaceuticals
SNOA
16 hedge funds and large institutions have $1.23M invested in Sonoma Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
14% more funds holding
Funds holding: 14 → 16 (+2)
12% more capital inflows, than outflows
Capital inflows: $93.9K | Capital outflows: $84K
0.05% more ownership
Funds ownership: 6.68% → 6.73% (+0.05%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$45.1K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$21K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$17.3K |
| 4 |
Morgan Stanley
New York
|
+$4.51K |
| 5 |
Advisor Group
Phoenix,
Arizona
|
+$3.76K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$75K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$4.51K |
| 3 |
Bard Associates
Chicago,
Illinois
|
-$3.76K |
| 4 |
MSI Financial Services
Springfield,
Massachusetts
|
-$751 |
SNOA Hedge Fund Activity: Q3 2016 in Review
16 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q3 2016, worth a combined $1.23M — up 8.8% from $1.13M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new SNOA positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $45.1K. The largest seller was B. Riley Wealth Advisors, exiting entirely with an estimated $75K sold.
- 16 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q3 2016, up from 14 in Q2 2016.
- Funds reported $1.23M of Sonoma Pharmaceuticals stock for Q3 2016, up 8.8% quarter-over-quarter.
- 4 funds opened new Sonoma Pharmaceuticals positions in Q3 2016 and 2 closed out, a net change of +2 holders.
- The largest Sonoma Pharmaceuticals buyer in Q3 2016 was Susquehanna International Group, an estimated $45.1K added.
- The largest Sonoma Pharmaceuticals seller in Q3 2016 was B. Riley Wealth Advisors, an estimated $75K sold.
Based on aggregated 13F filings for Q3 2016.